MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/all.13875

Медицинская библиотека · Allergy · 2019

EUFOREA consensus on biologics for CRSwNP with or without asthma.

Fokkens Wytske J, Lund Valerie, Bachert Claus, Mullol Joaquim, Bjermer Leif, Bousquet Jean, Canonica Giorgio W, Deneyer Lauren, Desrosiers Martin, Diamant Zuzana, Han Joseph, Heffler Enrico, Hopkins Claire, Jankowski Roger, Joos Guy, Knill Andrew, Lee Jivianne, Lee Stella E, Mariën Gert, Pugin Benoit, Senior Brent, Seys Sven F, Hellings Peter W

Consensus StatementСтатьяОбзорПеревод пока не подготовлен

Аннотация

Novel therapies such as type 2 targeting biologics are emerging treatment options for patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely uncontrolled patients. The majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and over half of patients with asthma show a type 2 inflammatory signature in sinonasal mucosa and/or lungs. Importantly, both chronic respiratory diseases are frequent comorbidities, ensuring alleviation of both upper and lower airway pathology by systemic biological therapy. Type 2-targeting biologics such as anti-IgE, anti-IL4Rα, anti-IL5, and anti-IL5Rα have entered the market for selected pheno/endotypes of asthma patients and may soon also become available for CRSwNP patients. Given the high prevalence of chronic respiratory diseases and the high cost associated with biologics, patient selection is crucial in order to implement such therapies into chronic respiratory disease care pathways. The European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) organized a multidisciplinary Expert Board Meeting to discuss the positioning of biologics into the care pathways for CRSwNP patients with and without comorbid asthma.

Для цитирования: Fokkens Wytske J, Lund Valerie, Bachert Claus, Mullol Joaquim, Bjermer Leif, Bousquet Jean, Canonica Giorgio W, Deneyer Lauren, Desrosiers Martin, Diamant Zuzana, Han Joseph, Heffler Enrico, Hopkins Claire, Jankowski Roger, Joos Guy, Knill Andrew, Lee Jivianne, Lee Stella E, Mariën Gert, Pugin Benoit, Senior Brent, Seys Sven F, Hellings Peter W. EUFOREA consensus on biologics for CRSwNP with or without asthma.. Allergy. 2019. DOI: 10.1111/all.13875.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.